Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis

Inclusion criteria

• Diagnosed with bacterial conjunctivitis in 1 or both eyes;
• Able to understand and sign an informed consent form. If subject is <18 years of age, the informed consent must be understood and signed by the subject's legally authorized representative;
• Agrees to comply with the visit schedule and other requirements of the study;
• Other protocol-specified inclusion criteria may apply.

Exclusion criteria

• Signs and symptoms of bacterial conjunctivitis for longer than 4 days prior to Day 1;
• Presence of concomitant viral infection;
• Infants with ophthalmia neonatorum of gonococcal, Chlamydia, herpetic or chemical origin;
• Infants whose birth mothers had any sexually transmitted disease within 1 month prior to delivery;
• Infants undergoing treatment for retinopathy of prematurity;
• Contact lens wear during the course of the study;
• Only 1 sighted eye or vision in either eye not correctable to 0.6 logMAR units (20/80) or better;
• Use of medications, as specified in the protocol;
• Any systemic or ocular disease or disorder, complicating factors or structural abnormality that could negatively affect the conduct or outcome of the study;
• Known or suspected allergy or hypersensitivity to fluoroquinolones;
• Pregnant, lactating, or of childbearing potential and not using adequate birth control to prevent pregnancy;
• Other protocol-specified exclusion criteria may apply.